Skip to main content

ProShares Trust II

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

SCO$20.19+2.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

ProShares Ultra Euro

September 30, 2026 (unaudited)December 31, 2025
Assets
Short-term U.S. government and agency obligations (Note 3) (cost $995,019 and $–, respectively)$994,861$—
Cash2,880,7725,185,710
Segregated cash balances with brokers for foreign currency forward contracts—666,667
Unrealized appreciation on foreign currency forward contracts17,40662,719
Interest receivable9,51815,545
Total assets3,902,5575,930,641
Liabilities and shareholders’ equity
Liabilities
Payable to Sponsor3,2914,756
Unrealized depreciation on foreign currency forward contracts256,91529
Total liabilities260,2064,785
Commitments and Contingencies (Note 2)
Shareholders’ equity
Shareholders’ equity3,642,3515,925,856
Total liabilities and shareholders’ equity$3,902,557$5,930,641
Shares outstanding300,000450,000
Net asset value per share$12.14$13.17
Market value per share (Note 2)$12.13$13.16
Principal AmountValue
Short-term U.S. government and agency obligations
(27% of shareholders’ equity)
U.S. Treasury Bills^^:
3.920% due 11/17/2026†$1,000,000$994,861
Total short-term U.S. government and agency obligations (cost $995,019)$994,861

^

Settlement DateContract Amount in Local CurrencyContract Amount in U.S. DollarsUnrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Euro with Goldman Sachs International10/09/263,528,921$3,997,834$(117,329)
Euro with UBS AG10/09/264,170,5024,724,666(139,586)
Total Unrealized Depreciation$(256,915)
Contracts to Sell
Euro with Goldman Sachs International10/09/26(73,000)$(82,700)$315
Euro with UBS AG10/09/26(1,188,000)(1,345,858)17,091
Total Unrealized Appreciation$17,406
†All or partial amount pledged as collateral for foreign currency forward contracts.
^The positions and counterparties herein are as of September 30, 2026. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.
^^Rates shown represent discount rate at the time of purchase.
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Investment Income
Interest$39,432$72,530$133,619$186,574
Total income39,43272,530133,619186,574
Expenses
Management fee10,51718,71838,38748,609
Total expenses10,51718,71838,38748,609
Net investment income (loss)28,91553,81295,232137,965
Realized and unrealized gain (loss) on investment activity
Net realized gain (loss) on
Foreign currency forward contracts18,626220,691(206,158)997,841
Net realized gain (loss)18,626220,691(206,158)997,841
Change in net unrealized appreciation (depreciation) on
Foreign currency forward contracts(113,669)(434,179)(302,199)176,469
Short-term U.S. government and agency obligations(104)—(158)—
Change in net unrealized appreciation (depreciation)(113,773)(434,179)(302,357)176,469
Net realized and unrealized gain (loss)(95,147)(213,488)(508,515)1,174,310
Net income (loss)$(66,232)$(159,676)$(413,283)$1,312,275
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Shareholders’ equity, beginning of period$4,949,960$8,708,069$5,925,856$5,751,156
Addition of –, –, 50,000 and 200,000 shares, respectively——679,8572,513,699
Redemption of 100,000, 100,000, 200,000 and 200,000 shares, respectively(1,241,377)(1,276,289)(2,550,079)(2,305,026)
Net addition (redemption) of (100,000), (100,000), (150,000) and – shares, respectively(1,241,377)(1,276,289)(1,870,222)208,673
Net investment income (loss)28,91553,81295,232137,965
Net realized gain (loss)18,626220,691(206,158)997,841
Change in net unrealized appreciation (depreciation)(113,773)(434,179)(302,357)176,469
Net income (loss)(66,232)(159,676)(413,283)1,312,275
Shareholders’ equity, end of period$3,642,351$7,272,104$3,642,351$7,272,104
Nine Months Ended September 30,
20262025
Cash flow from operating activities
Net income (loss)$(413,283)$1,312,275
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Purchases of short-term U.S. government and agency obligations(5,962,322)—
Proceeds from sales or maturities of short-term U.S. government and agency obligations5,000,000—
Net amortization and accretion on short-term U.S. government and agency obligations(32,697)—
Change in unrealized (appreciation) depreciation on investments302,357(176,469)
Decrease (Increase) in interest receivable6,027(2,005)
Increase (Decrease) in payable to Sponsor(1,465)939
Net cash provided by (used in) operating activities(1,101,383)1,134,740
Cash flow from financing activities
Proceeds from addition of shares679,8572,513,699
Payment on shares redeemed(2,550,079)(2,305,026)
Net cash provided by (used in) financing activities(1,870,222)208,673
Net increase (decrease) in cash(2,971,605)1,343,413
Cash, beginning of period5,852,3775,903,547
Cash, end of period$2,880,772$7,246,960
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.